Microalbuminuria: Undervalued As A Risk Assessment Tool

hermann haller Microalbuminuria: Undervalued As A Risk Assessment Tool

Hermann Haller

Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction and stroke—which are going undetected across Europe because doctors are not testing their patients who have hypertension for microalbuminuria. He discusses the findings of a European Society of Hypertension survey revealing widespread ignorance among general practitioners, cardiologists and diabetologists.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

This entry was posted in Cardiovascular. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>